These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19536842)

  • 1. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina.
    Atwater BD; Oujiri J; Wolff MR
    Clin Cardiol; 2009 Aug; 32(8):E1-3. PubMed ID: 19536842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
    Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the use of various medications amongst patients with severe coronary artery disease. SECOR/SBU Project Group.
    Herlitz J; Brorsson B; Werkö L
    J Intern Med; 1999 Feb; 245(2):143-53. PubMed ID: 10081517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year perspective on COURAGE.
    Tommaso CL
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):426-429. PubMed ID: 18727125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of medical therapy for chronic stable angina.
    Eid F; Boden WE
    Curr Cardiol Rep; 2008 Jul; 10(4):263-71. PubMed ID: 18611360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of stable angina pectoris. "Mother Courage and her children"].
    Nagy V; Czuriga I
    Orv Hetil; 2008 Feb; 149(7):291. PubMed ID: 18258558
    [No Abstract]   [Full Text] [Related]  

  • 16. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in PCI volume after negative results from the COURAGE trial.
    Howard DH; Shen YC
    Health Serv Res; 2014 Feb; 49(1):153-70. PubMed ID: 23829189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy after successful percutaneous coronary revascularization.
    Hasdai D; Lerman A; Grill DE; Rihal CS; Holmes DR
    Ann Intern Med; 1999 Jan; 130(2):108-15. PubMed ID: 10068356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy versus percutaneous coronary interventions for patients with stable and unstable coronary artery disease.
    Pitt B
    Curr Atheroscler Rep; 2008 Aug; 10(4):288-94. PubMed ID: 18606099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials.
    Rashid M; Stevens C; Wijeysundera HC; Curzen N; Khoo CW; Mohamed MO; Aktaa S; Wu J; Ludman PF; Mamas MA
    J Am Heart Assoc; 2022 Sep; 11(18):e025426. PubMed ID: 36102261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.